EPO Patents = 2

Trademarks = 11

Forward Citations = 3

Loading Chart...

10 inventors (with patents filed for the assignee):

Lei Yin (3 out of 5 patents)

Wenjian Liu (3 out of 5 patents)

Heng Li (3 out of 11 patents)

4. Dianxi Zhu (2 out of 2 patents)

5. Yin Lei (1 out of 1 patent)

6. Yao Zhenglin (1 out of 1 patent)

7. Li Heng (1 out of 1 patent)

8. Wenjie Li (1 out of 4 patents)

9. Damei Wang (1 out of 1 patent)

10. Jinlei Zhang (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 11787801 - Protein kinase inhibitors, preparation method and medical use thereof (2023-10-17),

2. 11339171 - MDM2 inhibitors (2022-05-24),

3. 11091476 - Protein kinase inhibitors, preparation method and medical use thereof (2021-08-17),

4. 10696678 - Kinase inhibitor, and preparing method and pharmaceutical use thereof (2020-06-30),

5. 9187520 - Method for preparing insulin glargine crystal (2015-11-17),

Gan & Lee Pharmaceuticals is a leading biopharmaceutical company dedicated to the research, development, production, and commercialization of insulin and diabetes therapeutics. With a focus on innovation and quality, Gan & Lee is committed to improving the lives of patients worldwide. The company's extensive portfolio includes a range of insulin products as well as other treatments for diabetes and related conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

5 Patents

#415 in Beijing

#4,575 in China

Beijing, China

Gan & Lee Pharmaceuticals